Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

This study aimed to differentiate human mesenchymal stem cells (hMSCs) from the human umbilical cord in cholinergic-like neurons using a natural membrane. The isolation of hMSCs from Wharton’s jelly (WJ) was carried out using “explant” and mononuclear cells by the density gradient from umbilical blood and characterized by flow cytometry. hMSCs were seeded in a natural functional biopolymer membrane to produce neurospheres. RT-PCR was performed on hMSCs and neurospheres derived from the umbilical cord. Neural precursor cells were subjected to a standard cholinergic-like neuron differentiation protocol. Dissociated neurospheres, neural precursor cells, and cholinergic-like neurons were characterized by immunocytochemistry. hMSCs were CD73+, CD90+, CD105+, CD34- and CD45- and demonstrated the trilineage differentiation. Neurospheres and their isolated cells were nestin-positive and expressed NESTIN, MAP2, ßIII-TUBULIN, GFAP genes. Neural precursor cells that were differentiated in cholinergic-like neurons expressed ßIII-TUBULIN protein and choline acetyltransferase enzyme. hMSCs seeded on the natural membrane can differentiate into neurospheres, obtaining neural precursor cells without growth factors or gene transfection before cholinergic phenotype differentiation.

Details

Title
Human Mesenchymal Stem Cells Seeded on the Natural Membrane to Neurospheres for Cholinergic-like Neurons
Author
Priscila Elias Ferreira Stricker 1   VIAFID ORCID Logo  ; Daiany de Souza Dobuchak 1   VIAFID ORCID Logo  ; Irioda, Ana Carolina 1 ; Bassam Felipe Mogharbel 1   VIAFID ORCID Logo  ; Celia Regina Cavichiolo Franco 2 ; José Roberto de Souza Almeida Leite 3   VIAFID ORCID Logo  ; Alyne Rodrigues de Araújo 4   VIAFID ORCID Logo  ; Felipe Azevedo Borges 5 ; Rondinelli Donizetti Herculano 5 ; Carlos Frederico de Oliveira Graeff 6   VIAFID ORCID Logo  ; Chachques, Juan Carlos 7 ; Katherine Athayde Teixeira de Carvalho 1   VIAFID ORCID Logo 

 Advanced Therapy and Cellular Biotechnology in Regenerative Medicine Department, Child and Adolescent Health Research and Pequeno Príncipe Faculties, Pelé Pequeno Príncipe Institute, Curitiba 80240-020, Brazil; [email protected] (P.E.F.S.); [email protected] (D.d.S.D.); [email protected] (A.C.I.); [email protected] (B.F.M.) 
 Cell Biology Department, Federal University of Paraná, Curitiba 81530-000, Brazil; [email protected] 
 Research Center in Applied Morphology and Immunology, NuPMIA, Faculty of Medicine, University of Brasília, Brasília 70910-900, Brazil; [email protected] 
 Biodiversity and Biotechnology Research, Parnaíba Delta Federal University, Parnaíba 64202-020, Brazil; [email protected] 
 Faculty of Pharmaceutics Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil; [email protected] (F.A.B.); [email protected] (R.D.H.) 
 Physics Department, São Paulo State University (UNESP), Bauru 17033-360, Brazil; [email protected] 
 Laboratory Biosurgical Research, Cardiovascular Division, Pompidou Hospital, University of Paris, 75015 Paris, France; [email protected] 
First page
598
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20770375
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2565404809
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.